Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pfizer to develop and commercialize OPKO’s long-acting human growth hormone
The drug is used for growth deficiency in adults and children as well as for growth failure in babies born small who fail to catch up growth by
The drug is used for growth deficiency in adults and children as well as for growth failure in babies born small who fail to catch up growth by
The Phase III LUX-Breast 1 trial compared afatinib plus vinorelbine (experimental arm) with trastuzumab plus vinorelbine in patients with HER2-positive metastatic breast cancer after failure of prior trastuzumab-based
Patient enrollment in the Phase II clinical trial will be initiated as soon as possible, according to the company. AC-201 has shown the ability to inhibit the production
The license agreement replaces the prior development and collaboration agreement, under which the two firms were jointly developing ONT-380. Under the license deal, Oncothyreon will pay Array $20m
For three years, the vaccine has been available in trivalent formulation and now it is available in a quadrivalent formulation to help protect against four strains of influenza
The US Food and Drug Administration (FDA) and European Medicines Agency (EMA) have also granted orphan drug designation for selinexor to treat patients with DLBCL. The Phase IIb
The US FDA has also granted fast track designation to defibrotide for the treatment of severe VOD. In its severe form, VOD can be life-threatening and is related
NSCLC occurs when cancer cells form in the lung’s tissues. According to estimates by the National Cancer Institute, about 224,210 individuals in the US are expected to be
If approved, the trial will evaluate the safety and tolerability of increasing doses of Nu-3 when applied topically as well as collect data on the changes in the
Under the deal, X-Chem will deploy its drug discovery engine, which is based on an ultra-large, high-diversity library in excess of 100 billion molecules, to identify new drug